Mymetics Corp (MYMX)

[MERCURIAL]

Morning. Confidence is found after you've scoured the web for all DD on a company. The price is lower than it should be, and Mymetics is working with some the most competent scientists in the world. It has a pipeline of research that takes a different approach on vaccine production. If proved successful, it could not only be profitable for the company but applicable to the treatment of other viruses not yet in the pipeline.

Insiders have provided the bulk of the funding for the research, and the debt they have shouldn't be subject to rampant dilution. That being said, if the trials with Sanofi show promise, there is always a chance that a large vaccine company will want this technology before it is developed into a multi-billion dollar revenue stream for someone else? $MYMX